Breaking News Instant updates and real-time market news.

KSS

Kohl's

$27.38 /

-1.97 (-6.71%)

06:39
07/07/22
07/07
06:39
07/07/22
06:39

Kohl's downgraded to Underperform from Neutral at BofA

BofA analyst Lorraine Hutchinson downgraded Kohl's to Underperform from Neutral with a price target of $26, down from $50. Her rating is now aligned with her negative view on the department store industry, said Hutchinson, who previously had been concerned about fundamentals but held a neutral view on the stock given the possibility of a takeout. With a deal "off the table," she sees risk to estimates and the stock from here, the analyst tells investors.

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Nvidia price target lowered to $250 from $290 at Mizuho » 06:41
08/09/22
08/09
06:41
08/09/22
06:41
NVDA

Nvidia

$177.97 /

-11.97 (-6.30%)

Mizuho analyst Vijay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

08/08/22 Summit Insights
Nvidia underestimated its exposure to crypto mining, says Summit Insights
08/08/22 Oppenheimer
Nvidia price target lowered to $250 from $300 at Oppenheimer
08/08/22 Truist
Nvidia price target lowered to $216 from $283 at Truist
08/08/22 Craig-Hallum
Craig-Hallum downgrades 'too expensive' Nvidia after guidance cut
NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

NVDA Nvidia
$177.97 /

-11.97 (-6.30%)

Recommendations
Freshpet price target lowered to $90 from $100 at Baird » 06:41
08/09/22
08/09
06:41
08/09/22
06:41
FRPT

Freshpet

$56.39 /

+1.895 (+3.48%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

05/20/22 Atlantic Equities
Atlantic Equities sees more volatility for Freshpet, downgrades shares
05/20/22 Atlantic Equities
Freshpet downgraded to Neutral from Overweight at Atlantic Equities
05/03/22 Cowen
Freshpet price target lowered to $163 from $181 at Cowen
05/03/22 Oppenheimer
Freshpet price target lowered to $110 from $120 at Oppenheimer
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

  • 04
    May
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

Earnings
Planet Fitness sees FY22 adjusted EPS up mid-80% range » 06:40
08/09/22
08/09
06:40
08/09/22
06:40
PLNT

Planet Fitness

$81.08 /

+0.71 (+0.88%)

Sees FY22 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

07/07/22 Exane BNP Paribas
Planet Fitness upgraded to Neutral from Underperform at Exane BNP Paribas
06/13/22 Jefferies
Jefferies names five top picks in lifestyle and growth platforms
06/07/22 Cowen
Planet Fitness positioned to succeed despite macro challenges, says Cowen
05/25/22 Cowen
Planet Fitness operating model remains resilient among headwinds, says Cowen
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

Recommendations
LivePerson price target lowered to $14 from $18 at Mizuho » 06:40
08/09/22
08/09
06:40
08/09/22
06:40
LPSN

LivePerson

$16.54 /

+0.775 (+4.92%)

Mizuho analyst Siti…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPSN LivePerson
$16.54 /

+0.775 (+4.92%)

LPSN LivePerson
$16.54 /

+0.775 (+4.92%)

06:10 Today Loop Capital
LivePerson downgraded to Hold from Buy at Loop Capital
07/26/22 Jefferies
LivePerson price target lowered to $15 from $18 at Jefferies
05/23/22 Jefferies
LivePerson price target lowered to $18 from $23 at Jefferies
05/10/22 B. Riley
LivePerson price target lowered to $19 from $23 at B. Riley
LPSN LivePerson
$16.54 /

+0.775 (+4.92%)

LPSN LivePerson
$16.54 /

+0.775 (+4.92%)

Recommendations
Upstart price target lowered to $23 from $28 at Stephens » 06:39
08/09/22
08/09
06:39
08/09/22
06:39
UPST

Upstart

$32.30 /

+2.71 (+9.16%)

Stephens analyst Vincent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UPST Upstart
$32.30 /

+2.71 (+9.16%)

UPST Upstart
$32.30 /

+2.71 (+9.16%)

07/22/22 Morgan Stanley
Berkshire Hills halting additions of new Upstart loans, says Morgan Stanley
07/18/22 Piper Sandler
Upstart price target lowered to $25 from $44 at Piper Sandler
07/17/22 Barclays
Upstart price target lowered to $25 from $35 at Barclays
07/15/22 Morgan Stanley
Upstart price target lowered to $15.50 from $19 at Morgan Stanley
UPST Upstart
$32.30 /

+2.71 (+9.16%)

UPST Upstart
$32.30 /

+2.71 (+9.16%)

UPST Upstart
$32.30 /

+2.71 (+9.16%)

Recommendations
Karuna Therapeutics price target raised to $276 from $190 at Mizuho » 06:39
08/09/22
08/09
06:39
08/09/22
06:39
KRTX

Karuna Therapeutics

$241.52 /

+101.41 (+72.38%)

Mizuho analyst Vamil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

06:33 Today Citi
Zai Lab price target raised to $199 from $193 at Citi
06:25 Today BofA
Karuna Therapeutics price target raised to $261 from $160 at BofA
08/08/22 Stifel
Cerevel Therapeutics price target raised to $54 from $50 at Stifel
08/08/22 Stifel
Karuna Therapeutics price target raised to $260 from $185 at Stifel
KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

  • 10
    Aug
  • 10
    Nov
KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

Earnings
FTC Solar sees Q3 revenue $16.5M-$19M, consensus $51.93M » 06:39
08/09/22
08/09
06:39
08/09/22
06:39
FTCI

FTC Solar

$4.93 /

+0.06 (+1.23%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FTCI FTC Solar
$4.93 /

+0.06 (+1.23%)

FTCI FTC Solar
$4.93 /

+0.06 (+1.23%)

07/19/22 Northland
Shoals Technologies cut to Market Perform at Northland after Manchin news
07/19/22 Piper Sandler
FTC Solar upgraded to Neutral from Underweight at Piper Sandler
07/19/22 Piper Sandler
FTC Solar upgraded to Neutral from Underweight at Piper Sandler
07/15/22 Northland
Sunworks and Sunnova could trade down on Manchin news, says Northland
FTCI FTC Solar
$4.93 /

+0.06 (+1.23%)

FTCI FTC Solar
$4.93 /

+0.06 (+1.23%)

FTCI FTC Solar
$4.93 /

+0.06 (+1.23%)

Earnings
ESAB reports Q2 adjusted EPS $1.14, consensus $1.01 » 06:38
08/09/22
08/09
06:38
08/09/22
06:38
ESAB

ESAB

$44.19 /

-0.445 (-1.00%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESAB ESAB
$44.19 /

-0.445 (-1.00%)

ESAB ESAB
$44.19 /

-0.445 (-1.00%)

07/18/22 Stifel
ESAB price target lowered to $45 from $56 at Stifel
05/20/22 Stifel
ESAB initiated with a Buy at Stifel
05/13/22 Loop Capital
ESAB initiated with a Hold at Loop Capital
ESAB ESAB
$44.19 /

-0.445 (-1.00%)

Downgrade
Turtle Beach downgraded to Perform from Outperform at Oppenheimer » 06:38
08/09/22
08/09
06:38
08/09/22
06:38
HEAR

Turtle Beach

$14.00 /

-0.145 (-1.03%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

08/04/22 Wedbush
Turtle Beach price target lowered to $22 from $27 at Wedbush
07/06/22 DA Davidson
Turtle Beach price target lowered to $25 from $30 at DA Davidson
05/17/22 Wedbush
Wedbush upgrades Turtle Beach to Outperform on higher chance of deal
05/17/22 Wedbush
Turtle Beach upgraded to Outperform from Neutral at Wedbush
HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

HEAR Turtle Beach
$14.00 /

-0.145 (-1.03%)

Recommendations
FleetCor price target raised to $256 from $250 at Mizuho » 06:38
08/09/22
08/09
06:38
08/09/22
06:38
FLT

FleetCor

$227.37 /

+1.62 (+0.72%)

Mizuho analyst Dan Dolev…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLT FleetCor
$227.37 /

+1.62 (+0.72%)

FLT FleetCor
$227.37 /

+1.62 (+0.72%)

08/08/22 Barclays
FleetCor price target raised to $295 from $286 at Barclays
07/27/22 Mizuho
FleetCor price target lowered to $250 from $275 at Mizuho
07/19/22 Barclays
FleetCor price target lowered to $286 from $312 at Barclays
06/30/22 Truist
FleetCor price target lowered to $275 from $290 at Truist
FLT FleetCor
$227.37 /

+1.62 (+0.72%)

FLT FleetCor
$227.37 /

+1.62 (+0.72%)

Earnings
FTC Solar reports Q2 EPS (26c), consensus (16c) » 06:37
08/09/22
08/09
06:37
08/09/22
06:37
FTCI

FTC Solar

$4.93 /

+0.06 (+1.23%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FTCI FTC Solar
$4.93 /

+0.06 (+1.23%)

FTCI FTC Solar
$4.93 /

+0.06 (+1.23%)

07/19/22 Northland
Shoals Technologies cut to Market Perform at Northland after Manchin news
07/19/22 Piper Sandler
FTC Solar upgraded to Neutral from Underweight at Piper Sandler
07/19/22 Piper Sandler
FTC Solar upgraded to Neutral from Underweight at Piper Sandler
07/15/22 Northland
Sunworks and Sunnova could trade down on Manchin news, says Northland
FTCI FTC Solar
$4.93 /

+0.06 (+1.23%)

FTCI FTC Solar
$4.93 /

+0.06 (+1.23%)

FTCI FTC Solar
$4.93 /

+0.06 (+1.23%)

Earnings
Planet Fitness reports Q2 adjusted EPS 38c vs. 21c last year » 06:37
08/09/22
08/09
06:37
08/09/22
06:37
PLNT

Planet Fitness

$81.08 /

+0.71 (+0.88%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

07/07/22 Exane BNP Paribas
Planet Fitness upgraded to Neutral from Underperform at Exane BNP Paribas
06/13/22 Jefferies
Jefferies names five top picks in lifestyle and growth platforms
06/07/22 Cowen
Planet Fitness positioned to succeed despite macro challenges, says Cowen
05/25/22 Cowen
Planet Fitness operating model remains resilient among headwinds, says Cowen
PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

PLNT Planet Fitness
$81.08 /

+0.71 (+0.88%)

Recommendations
Acadia Pharmaceuticals price target lowered to $19 from $27 at Mizuho » 06:36
08/09/22
08/09
06:36
08/09/22
06:36
ACAD

Acadia Pharmaceuticals

$16.65 /

+0.225 (+1.37%)

Mizuho analyst Vamil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

06:23 Today H.C. Wainwright
Acadia Pharmaceuticals price target raised to $25 from $20 at H.C. Wainwright
05:40 Today Citi
Acadia Pharmaceuticals price target raised to $17 from $15 at Citi
08/08/22 Cowen
Acadia Pharmaceuticals price target lowered to $21 from $32 at Cowen
08/05/22 Citi
Acadia Pharmaceuticals downgraded to Neutral from Buy at Citi
ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

Earnings
Beam Therapeutics reports Q2 EPS ($1.02), consensus ($1.08) » 06:36
08/09/22
08/09
06:36
08/09/22
06:36
BEAM

Beam Therapeutics

$63.74 /

+0.4 (+0.63%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BEAM Beam Therapeutics
$63.74 /

+0.4 (+0.63%)

BEAM Beam Therapeutics
$63.74 /

+0.4 (+0.63%)

07/18/22 BMO Capital
Beam Therapeutics price target raised to $61 from $41 at BMO Capital
06/16/22 BMO Capital
Beam Therapeutics initiated with a Market Perform at BMO Capital
04/28/22 Credit Suisse
Beam Therapeutics initiated with a Neutral at Credit Suisse
01/10/22 Wedbush
Beam Therapeutics price target raised to $159 from $148 at Wedbush
BEAM Beam Therapeutics
$63.74 /

+0.4 (+0.63%)

BEAM Beam Therapeutics
$63.74 /

+0.4 (+0.63%)

Earnings
Perrigo cuts FY22 adjusted EPS view to $2.25-$2.35 from $2.30-$2.40 » 06:35
08/09/22
08/09
06:35
08/09/22
06:35
PRGO

Perrigo

$42.63 /

-0.36 (-0.84%)

Backs FY22 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRGO Perrigo
$42.63 /

-0.36 (-0.84%)

PRGO Perrigo
$42.63 /

-0.36 (-0.84%)

05/31/22 Jefferies
Perrigo transferred with a Buy at Jefferies
11/11/21 Raymond James
Perrigo price target lowered to $55 from $59 at Raymond James
10/14/21
Fly Intel: Top five analyst upgrades
10/14/21 Raymond James
Raymond James upgrades Perrigo to buy on HRA deal, tax settlement
PRGO Perrigo
$42.63 /

-0.36 (-0.84%)

PRGO Perrigo
$42.63 /

-0.36 (-0.84%)

Earnings
Verve Therapeutics reports Q2 EPS (84c), consensus (63c) » 06:35
08/09/22
08/09
06:35
08/09/22
06:35
VERV

Verve Therapeutics

$27.11 /

+0.46 (+1.73%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VERV Verve Therapeutics
$27.11 /

+0.46 (+1.73%)

VERV Verve Therapeutics
$27.11 /

+0.46 (+1.73%)

07/18/22 BMO Capital
Verve Therapeutics price target raised to $62 from $48 at BMO Capital
06/16/22 BMO Capital
Verve Therapeutics initiated with an Outperform at BMO Capital
03/14/22 Stifel
Verve Therapeutics price target lowered to $34 from $58 at Stifel
02/17/22 RBC Capital
RBC Capital starts Verve Therapeutics at Outperform on 'disruptive' treatment
VERV Verve Therapeutics
$27.11 /

+0.46 (+1.73%)

  • 21
    Jul
VERV Verve Therapeutics
$27.11 /

+0.46 (+1.73%)

Recommendations
10x Genomics price target lowered to $65 from $100 at Citi » 06:35
08/09/22
08/09
06:35
08/09/22
06:35
TXG

10x Genomics

$43.45 /

+0.83 (+1.95%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TXG 10x Genomics
$43.45 /

+0.83 (+1.95%)

TXG 10x Genomics
$43.45 /

+0.83 (+1.95%)

07/25/22 Canaccord
Canaccord starts 10x Genomics at Buy, sees multiple avenues for long-term growth
07/25/22 Canaccord
10x Genomics initiated with a Buy at Canaccord
07/15/22 Morgan Stanley
10x Genomics reset a 'clearing event,' says Morgan Stanley
07/15/22 BofA
BofA sees 'no quick fix' for 10x Genomics, downgrades to Underperform
TXG 10x Genomics
$43.45 /

+0.83 (+1.95%)

TXG 10x Genomics
$43.45 /

+0.83 (+1.95%)

Hot Stocks
Aramark reports 'record-level new client wins' » 06:34
08/09/22
08/09
06:34
08/09/22
06:34
ARMK

Aramark

$35.27 /

+0.16 (+0.46%)

Aramark is driving…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARMK Aramark
$35.27 /

+0.16 (+0.46%)

ARMK Aramark
$35.27 /

+0.16 (+0.46%)

03/29/22 Deutsche Bank
Aramark initiated with a Hold at Deutsche Bank
03/11/22 BofA
Aramark reinstated with a Buy at BofA
12/10/21 Stifel
Aramark positioning for strategic transaction for Uniform business, says Stifel
12/09/21 Baird
Aramark 'raises the growth bar' with analyst day targets, says Baird
ARMK Aramark
$35.27 /

+0.16 (+0.46%)

Upgrade
Tellurian upgraded to Buy at BofA on natural gas tailwinds » 06:34
08/09/22
08/09
06:34
08/09/22
06:34
TELL

Tellurian

$3.41 /

+0.03 (+0.89%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TELL Tellurian
$3.41 /

+0.03 (+0.89%)

TELL Tellurian
$3.41 /

+0.03 (+0.89%)

06:08 Today BofA
Tellurian upgraded to Buy from Neutral at BofA
08/01/22 Evercore ISI
Tellurian downgraded to In Line from Outperform at Evercore ISI
08/01/22 Evercore ISI
Tellurian downgraded to In Line from Outperform at Evercore ISI
06/06/22 Credit Suisse
Tellurian price target lowered to $7 from $8 at Credit Suisse
TELL Tellurian
$3.41 /

+0.03 (+0.89%)

TELL Tellurian
$3.41 /

+0.03 (+0.89%)

TELL Tellurian
$3.41 /

+0.03 (+0.89%)

Recommendations
Zai Lab price target raised to $199 from $193 at Citi » 06:33
08/09/22
08/09
06:33
08/09/22
06:33
ZLAB

Zai Lab

$47.14 /

+1.75 (+3.86%)

, KRTX

Karuna Therapeutics

$241.52 /

+101.41 (+72.38%)

Citi analyst Yigal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZLAB Zai Lab
$47.14 /

+1.75 (+3.86%)

KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

ZLAB Zai Lab
$47.14 /

+1.75 (+3.86%)

05/12/22 Citi
Zai Lab price target lowered to $193 from $198 at Citi
03/17/22 Citi
Citi opens '90-day positive Catalyst Watch' on Zai Lab
02/23/22 Roth Capital
Repotrectinib 'adds another feather' in China, says Roth Capital
12/15/21 JPMorgan
Zai Lab weakness on 1155 bill 'overdone,' says JPMorgan
KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

06:25 Today BofA
Karuna Therapeutics price target raised to $261 from $160 at BofA
08/08/22 Stifel
Cerevel Therapeutics price target raised to $54 from $50 at Stifel
08/08/22 Stifel
Karuna Therapeutics price target raised to $260 from $185 at Stifel
08/08/22 JMP Securities
Karuna Therapeutics price target raised to $315 from $190 at JMP Securities
KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

  • 10
    Aug
  • 10
    Nov
ZLAB Zai Lab
$47.14 /

+1.75 (+3.86%)

KRTX Karuna Therapeutics
$241.52 /

+101.41 (+72.38%)

Earnings
Perrigo reports Q2 adjusted EPS 43c vs. 50c last year » 06:32
08/09/22
08/09
06:32
08/09/22
06:32
PRGO

Perrigo

$42.63 /

-0.36 (-0.84%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRGO Perrigo
$42.63 /

-0.36 (-0.84%)

PRGO Perrigo
$42.63 /

-0.36 (-0.84%)

05/31/22 Jefferies
Perrigo transferred with a Buy at Jefferies
11/11/21 Raymond James
Perrigo price target lowered to $55 from $59 at Raymond James
10/14/21
Fly Intel: Top five analyst upgrades
10/14/21 Raymond James
Raymond James upgrades Perrigo to buy on HRA deal, tax settlement
PRGO Perrigo
$42.63 /

-0.36 (-0.84%)

PRGO Perrigo
$42.63 /

-0.36 (-0.84%)

Earnings
Aramark raises FY22 organic revenue growth view to 31%-32% » 06:32
08/09/22
08/09
06:32
08/09/22
06:32
ARMK

Aramark

$35.27 /

+0.16 (+0.46%)

Prior view was 'at…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARMK Aramark
$35.27 /

+0.16 (+0.46%)

ARMK Aramark
$35.27 /

+0.16 (+0.46%)

03/29/22 Deutsche Bank
Aramark initiated with a Hold at Deutsche Bank
03/11/22 BofA
Aramark reinstated with a Buy at BofA
12/10/21 Stifel
Aramark positioning for strategic transaction for Uniform business, says Stifel
12/09/21 Baird
Aramark 'raises the growth bar' with analyst day targets, says Baird
ARMK Aramark
$35.27 /

+0.16 (+0.46%)

Upgrade
BofA upgraded Federal Realty to Buy as COVID hindrances are removed » 06:32
08/09/22
08/09
06:32
08/09/22
06:32
FRT

Federal Realty

$107.13 /

+1.29 (+1.22%)

BofA analyst Craig…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRT Federal Realty
$107.13 /

+1.29 (+1.22%)

FRT Federal Realty
$107.13 /

+1.29 (+1.22%)

06:08 Today BofA
Federal Realty upgraded to Buy from Neutral at BofA
08/04/22 Stifel
Federal Realty price target lowered to $123 from $133 at Stifel
07/21/22 Mizuho
Federal Realty price target lowered to $117 from $129 at Mizuho
07/15/22 Barclays
Federal Realty price target lowered to $122 from $142 at Barclays
FRT Federal Realty
$107.13 /

+1.29 (+1.22%)

Downgrade
Avalara downgraded to Hold from Buy at Berenberg » 06:31
08/09/22
08/09
06:31
08/09/22
06:31
AVLR

Avalara

$91.80 /

-3.955 (-4.13%)

Berenberg analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVLR Avalara
$91.80 /

-3.955 (-4.13%)

AVLR Avalara
$91.80 /

-3.955 (-4.13%)

04:55 Today BMO Capital
Avalara downgraded to Market Perform from Outperform at BMO Capital
08/08/22 Mizuho
Avalara downgraded to Neutral from Buy at Mizuho
08/08/22 Evercore ISI
Avalara downgraded to In Line from Outperform at Evercore ISI
08/08/22 Canaccord
Avalara downgraded to Hold from Buy at Canaccord
AVLR Avalara
$91.80 /

-3.955 (-4.13%)

AVLR Avalara
$91.80 /

-3.955 (-4.13%)

AVLR Avalara
$91.80 /

-3.955 (-4.13%)

Earnings
Aramark reports Q3 adjusted EPS 25c, consensus 24c » 06:30
08/09/22
08/09
06:30
08/09/22
06:30
ARMK

Aramark

$35.27 /

+0.16 (+0.46%)

Reports Q3 revenue $4.1B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARMK Aramark
$35.27 /

+0.16 (+0.46%)

ARMK Aramark
$35.27 /

+0.16 (+0.46%)

03/29/22 Deutsche Bank
Aramark initiated with a Hold at Deutsche Bank
03/11/22 BofA
Aramark reinstated with a Buy at BofA
12/10/21 Stifel
Aramark positioning for strategic transaction for Uniform business, says Stifel
12/09/21 Baird
Aramark 'raises the growth bar' with analyst day targets, says Baird
ARMK Aramark
$35.27 /

+0.16 (+0.46%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.